Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Event | August 17, 2015

A View from the Inside: In-House Counsel Round Table

Article | August 12, 2015

Process Patents Are Vital In Biotech — Why Not Extend Them?

Blog | August 10, 2015

FCC Releases Notice of Proposed Rulemaking on Approval Procedures for Radiofrequency Devices

Blog | August 10, 2015

The Second Circuit Avoids the "Registration" Question

News | July 30, 2015

Fish & Richardson Has Two Litigators Named "Trial Aces" by Law360

Blog | July 29, 2015

Sanofi Challenges Two Members of "Cabilly" Family of Patents

Blog | July 27, 2015

Judicial Review Available for Decision that a Patent Qualified for CBM Review; § 101 Review Appropriate in CBM Review

Blog | July 24, 2015

PTAB's Construction Must Be "Reasonable" In Light of All Intrinsic Evidence, PTAB May Require Patentee to Show Amended Claims Are Patentable Over All Prior Art of Record

Blog | July 24, 2015

District Courts Deciding Whether to Modify a Protective Order to Allow U.S. Discovery to Be Used in Foreign Litigation Must Consider Factors Relevant to Section 1782 Proceedings

Event | July 24, 2015

Consero 2015 Brand Protection & Anti-Counterfeiting Executive Roundtable

News | July 24, 2015

Fish & Richardson Achieves Highest-Ever Pro Bono National Ranking in 2015 Am Law 200 Survey by The American Lawyer

Article | July 23, 2015

How To Avoid FDA Regulation Of Your Mobile Medical App